IRIS
COSTA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.914
AS - Asia 1.538
EU - Europa 1.117
SA - Sud America 202
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 81
Totale 4.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.842
SG - Singapore 525
CN - Cina 441
VN - Vietnam 254
IT - Italia 229
SE - Svezia 201
IE - Irlanda 189
BR - Brasile 152
DE - Germania 112
HK - Hong Kong 98
FI - Finlandia 82
FR - Francia 76
ZA - Sudafrica 72
TR - Turchia 60
NL - Olanda 49
BD - Bangladesh 47
CA - Canada 47
GB - Regno Unito 35
AT - Austria 30
IN - India 25
AR - Argentina 19
CZ - Repubblica Ceca 17
RU - Federazione Russa 17
ES - Italia 14
PL - Polonia 13
MX - Messico 12
PH - Filippine 12
CI - Costa d'Avorio 11
JP - Giappone 11
LT - Lituania 11
RO - Romania 11
BE - Belgio 10
VE - Venezuela 8
PK - Pakistan 7
PY - Paraguay 7
TH - Thailandia 7
IQ - Iraq 6
KR - Corea 6
CL - Cile 5
IL - Israele 5
ID - Indonesia 4
KE - Kenya 4
KH - Cambogia 4
TW - Taiwan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
EC - Ecuador 3
MA - Marocco 3
SC - Seychelles 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
JM - Giamaica 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SM - San Marino 2
SN - Senegal 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 4.879
Salva come PNG Salva come JPEG
Città #
Ashburn 266
Singapore 259
Chandler 218
Dublin 188
San Jose 158
Santa Clara 121
Parma 106
Hong Kong 93
Dallas 86
Beijing 83
Ho Chi Minh City 76
Ann Arbor 74
New York 74
Johannesburg 70
Hanoi 65
Shanghai 58
Dearborn 54
Los Angeles 51
Boardman 47
Council Bluffs 47
Munich 41
Izmir 38
Lauterbourg 36
Nanjing 36
Princeton 32
Helsinki 26
Vienna 25
Shenyang 23
Toronto 22
Wilmington 21
Marseille 18
Columbus 17
Turku 17
Buffalo 16
Da Nang 14
Jinan 14
Kunming 14
Milan 14
Moscow 14
Bremen 13
Hebei 13
Kocaeli 13
Nanchang 13
Brno 12
Chicago 12
Abidjan 11
Warsaw 11
Brussels 10
Frankfurt am Main 10
Jiaxing 10
Montreal 10
Orem 10
San Mateo 10
The Dalles 10
Brooklyn 9
Redmond 9
Tokyo 9
Focsani 8
Hefei 8
São Paulo 8
Tianjin 8
Zhengzhou 8
Changsha 7
Denver 7
London 7
Stockholm 7
Woodbridge 7
Amsterdam 6
Düsseldorf 6
Hangzhou 6
Houston 6
Modena 6
Poplar 6
Rome 6
Seattle 6
Atlanta 5
Chennai 5
Chongqing 5
Dhaka 5
Fairfield 5
Haiphong 5
Madrid 5
Ottawa 5
Palermo 5
Phoenix 5
Rio de Janeiro 5
Salvador 5
Ankara 4
Belo Horizonte 4
Boston 4
Can Tho 4
Des Moines 4
Jakarta 4
Mumbai 4
Norwalk 4
Phnom Penh 4
Rio Saliceto 4
San Francisco 4
Torino 4
Tân Tiến 4
Totale 3.062
Salva come PNG Salva come JPEG
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 221
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 198
The Proteasome and Myeloma-Associated Bone Disease 192
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 190
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 185
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 183
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 176
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 174
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION 171
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 162
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 162
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 161
Improved scaffold biocompatibility through anti-Fibronectin aptamer functionalization 157
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 155
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 154
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 153
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma. 147
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 147
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 145
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 142
Oncolytic virotherapy and microenvironment in multiple myeloma 142
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 141
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 141
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 135
Possible targets to treat myeloma-related osteoclastogenesis 134
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 130
Il mieloma multiplo nell'era dei nuovi farmaci. Patogenesi 125
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 118
CD38: A target for immunotherapeutic approaches in multiple myeloma 113
PD-L1/PD-1 axis in multiple myeloma microenvironment and a possible link with CD38-mediated immune-suppression 111
Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14(+) Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis 104
Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis 96
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+ 93
Totale 4.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022159 0 5 10 14 3 0 28 10 14 11 8 56
2022/2023805 90 93 64 70 63 86 29 49 223 7 22 9
2023/2024333 16 30 10 6 23 104 36 17 9 14 11 57
2024/2025942 15 39 41 107 103 94 53 47 125 70 92 156
2025/20261.862 189 136 220 171 265 105 177 82 225 181 72 39
2026/202774 18 56 0 0 0 0 0 0 0 0 0 0
Totale 4.958